These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 857675)

  • 21. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation effects of oral contraception.
    Bonnar J
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1042-8. PubMed ID: 2960241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic changes in women using a monthly injectable contraceptive for one year.
    Meng YX; Jiang HY; Chen AJ; Lu FY; Yang H; Zhang MY; Shen KY; Sun DL; Shao QX; Fotherby K
    Contraception; 1990 Oct; 42(4):455-66. PubMed ID: 2124180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of oral contraceptives containing 50 microgram estrogen on blood coagulation in non-Caucasian women.
    Tsakok FH; Koh S; Ratnam SS
    Contraception; 1980 May; 21(5):505-27. PubMed ID: 7428360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptives and antithrombin III: variations by dosage and ABO blood group.
    Burkman RT; Bell WR; Zacur HA; Kimball AW
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1453-8; discussion 1458-60. PubMed ID: 2048592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
    Medhat IA; Toppozada HK; Rizk MA; Khowessah MM; Malek AT; Moghazi M
    Contraception; 1974 Apr; 9(4):379-92. PubMed ID: 4442281
    [No Abstract]   [Full Text] [Related]  

  • 30. An epidemiological study of the haemostatic and other effects of oral contraceptives.
    Meade TW; Brozović M; Chakrabarth R; Howarth DJ; North WR; Stirling Y
    Br J Haematol; 1976 Nov; 34(3):353-64. PubMed ID: 990177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progestational agents and blood coagulation. VII. Thromboembolic and other complications of oral contraceptive therapy in relationship to pretreatment levels of blood coagulation factors: summary report of a ten-year study.
    Ambrus JL; Mink IB; Courey NG; Niswander K; Moore RH; Ambrus CM; Lillie MA
    Am J Obstet Gynecol; 1976 Aug; 125(8):1057-62. PubMed ID: 133615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
    Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norgestimate: a clinical overview of a new progestin.
    Bringer J
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1969-77. PubMed ID: 1605287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemostasis profile in women taking low-dose oral contraceptives.
    David JL; Gaspard UJ; Gillain D; Raskinet R; Lepot MR
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):420-3. PubMed ID: 2142579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.